タイトル
検索に戻る
検索結果

結果:10件
(1から10までを表示します.)


グローバルセッション1
免疫療法
座長:里内美弥子1, 西尾 誠人2(兵庫県立がんセンター呼吸器内科1, がん研究会有明病院呼吸器内科2
*Fumihiro Tanaka1・Hiroyuki Ito2・Morihito Okada3・Shunichi Sugawara4・Yutaka Shio5・Keisuke Tomii6・Jiro Okami7・Noriaki Sakakura8・Kaoru Kubota9・Kazuya Takamochi10・Shinji Atagi11・Masahiro Tsuboi12・Satoshi Oizumi13・Norihiko Ikeda14・Yasuhisa Ohde15・Ives Ntambwe16・Javed Mahmood16・Junliang Cai16・Tetsuya Mitsudomi17
University Of Occupational And Environmental Health Hospital, Kitakyushu, Fukuoka, Japan1;Kanagawa Cancer Center, Yokohama, Kanagawa, Japan2;Hiroshima University Hospital, Minami-Ku Hiroshima, Japan3;Sendai Kousei Hospital, Sendai, Miyagi, Japan4;Fukushima Medical University Hospital, Hikarigaoka, Fukushima, Japan5;Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan6;Osaka International Cancer institute, Osaka city, Osaka, Japan7;Aichi Cancer Center Hospital, Nagoya, Aichi, Japan8;Nippon Medical School Hospital, Bunkyo City, Tokyo, Japan9;Juntendo University Hospital, Tokyo, Japan10;National Hospital Organization Kinki-Chuo Chest Medical Center, Sakai, Osaka, Japan11;National Cancer Center Hospital East, Kashiwa, Chiba, Japan12;Hokkaido Cancer Center, Sapporo, Hokkaido, Japan13;Tokyo Medical University Hospital, Shinjuku City, Tokyo, Japan14;Shizuoka Cancer Center, Sunto District, Shizuoka, Japan15;WW Medical Oncology, Bristol Myers Squibb, Princeton, NJ, USA16;Kindai University Hospital Osakasayama, Osaka, Japan17
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション1
免疫療法
座長:里内美弥子1, 西尾 誠人2(兵庫県立がんセンター呼吸器内科1, がん研究会有明病院呼吸器内科2
*Takayasu Kurata1・Naoyuki Nogami2・Hideo Saka3・Makoto Nishio4・Takaaki Tokito5・Toshiaki Takahashi6・Kazuo Kasahara7・Yoshihiro Hattori8・Eiki Ichihara9・Noriaki Adachi10・Kazuo Noguchi10・Paul Schwarzenberger11・Hidehito Horinouchi12
Department of Thoracic Oncology, Kansai Medical University, Osaka, Japan1;Department of Community Medicine, Pulmonology and Cardiology, Ehime University Graduate School of Medicine, Toon, Japan2;Department of Respiratory Medicine and Medical Oncology, National Hospital Organization Nagoya Medical Center, Nagoya, Japan3;Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan4;Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan5;Division of Thoracic Oncology, Shizuoka Cancer Center, Shuntougun, Japan6;Department of Respiratory Medicine, Kanazawa University Hospital, Kanazawa, Japan7;Department of Thoracic Oncology, Hyogo Cancer Center, Akashi, Japan8;Department of Allergy and Respiratory Medicine, Okayama University Hospital, Okayama, Japan9;MSD K.K., Tokyo, Japan10;Merck & Co., Inc., Rahway, NJ, USA11;Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan12
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション1
免疫療法
座長:里内美弥子1, 西尾 誠人2(兵庫県立がんセンター呼吸器内科1, がん研究会有明病院呼吸器内科2
*Nobuyuki Yamamoto1・Terufumi Kato2・Isamu Okamoto3・Fumio Imamura4・Makoto Nishio5・Shinji Atagi6・Tomonori Hirashima7・Hiroshi Tanaka8・Tatsuro Fukuhara9・Yasuharu Nakahara10・Nobuyuki Katakami11・Morihito Okada12・Takayasu Kurata13・Hidehito Horinouchi14・Hibiki Udagawa15・Kazuo Kasahara16・Noriaki Adachi17・Kazuo Noguchi17・Paul Schwarzenberger18・Shunichi Sugawara19
Wakayama Medical University, Wakayama, Japan1;Kanagawa Cancer Center, Yokohama, Japan2;Kyushu University, Fukuoka, Japan3;Osaka International Cancer Institute, Osaka, Japan4;The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan5;National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan6;Osaka Habikino Medical Center, Osaka, Japan7;Niigata Cancer Center Hospital, Niigata, Japan8;Miyagi Cancer Center, Natori, Japan9;Himeji Medical Center, Himeji, Japan10;Takarazuka City Hospital, Takarazuka, Japan11;Hiroshima University, Hiroshima, Japan12;Kansai Medical University, Osaka, Japan13;National Cancer Center Hospital, Tokyo, Japan14;National Cancer Center Hospital East, Kashiwa, Japan15;Kanazawa University Hospital, Ishikawa, Japan16;MSD K.K., Tokyo, Japan17;Merck & Co., Inc., Rahway, NJ, USA18;Sendai Kousei Hospital, Miyagi, Japan19
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション1
免疫療法
座長:里内美弥子1, 西尾 誠人2(兵庫県立がんセンター呼吸器内科1, がん研究会有明病院呼吸器内科2
*Hideaki Mizutani1・Kazuo Kasahara2・Keisuke Tomii3・Shuji Murakami4・Hidehito Hayashi5・Hiroyasu Kaneda6・Makoto Maemondo7・Koichi Minato8・Tetsuji Kawamura9・Yuki Misumi10・Takeshi Hisada11・Miyako Satouchi12・Katsuyuki Hotta13・Nan Hu14・Xiaoqing Zhang14・Judi Sylvester14・Satoshi Ikeda15
Saitama Cancer Center, Saitama, Japan1;Kanazawa University Hospital, Kanazawa, Japan2;Kobe City Medical Center General Hospital, Kobe, Japan3;Kanagawa Cancer Center, Kanagawa, Japan4;Kindai University Hospital, Osaka, Japan5;Osaka Metropolitan University Hospital, Osaka, Japan6;Iwate Medical University Hospital, Iwate, Japan7;Gunma Prefectural Cancer Center, Gunma, Japan8;National Hospital Organization Himeji Medical Center, Himeji, Japan9;Yokohama Municipal Citizen's Hospital, Yokohama, Japan10;Gunma University Hospital, Gunma, Japan11;Hyogo Cancer Center, Hyogo, Japan12;Okayama University Hospital, Okayama, Japan13;Bristol Myers Squibb, Princeton, NJ, USA14;Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan15
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション1
免疫療法
座長:里内美弥子1, 西尾 誠人2(兵庫県立がんセンター呼吸器内科1, がん研究会有明病院呼吸器内科2
*Makoto Nishio1・Yuichiro Ohe2・Satoshi Ikeda3・Toshihide Yokoyama4・Hidetoshi Hayashi5・Tatsuro Fukuhara6・Yuki Sato7・Hiroshi Tanaka8・Katsuyuki Hotta9・Shunichi Sugawara10・Haruko Daga11・Isamu Okamoto12・Kazuo Kasahara13・Tateaki Naito14・Li Li15・Ravi G. Gupta15・Judith Bushong15・Hideaki Mizutani16
Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan1;National Cancer Center Hospital, Chuo City, Tokyo, Japan2;Kanagawa Cardiovascular and Respiratory Center, Kanagawa, Japan3;Kurashiki Central Hospital, Kurashiki, Okayama, Japan4;Kindai University Hospital, Osaka, Japan5;Miyagi Cancer Center, Natori, Miyagi, Japan6;Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Japan7;Niigata Cancer Center Hospital, Chuo Ward, Niigata, Japan8;Okayama University Hospital, Okayama, Japan9;Sendai Kousei Hospital, Sendai, Miyagi, Japan10;Osaka City General Hospital, Miyakojima Ward, Osaka, Japan11;Kyushu University Hospital, Higashi Ward, Fukuoka, Japan12;Kanazawa University Hospital, Kanazawa, Ishikawa, Japan13;Shizuoka Cancer Center, Nagaizumi, Shizuoka, Japan14;Bristol Myers Squibb, Princeton, NJ, USA15;Saitama Cancer Center, Saitama, Japan16
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション2
分子標的治療
座長:前門戸 任1, 堀尾 芳嗣2(岩手医科大学内科学講座呼吸器内科1, 愛知県がんセンター呼吸器内科2
*阪本 智宏1・松原 太一2・高濱 隆幸3・横山 俊秀4・中村  敦5・時任 高章6・岡本 龍郎7・赤松 弘朗8・沖  昌英9・佐藤 悠城10・飛野 和則11・西村 邦裕12・平岡  学13・釼持 広知14・藤本 淳也15・下川 元継16・山本 信之8・中川 和彦3
鳥取大学1;北九州市立医療センター2;近畿大学3;倉敷中央病院4;仙台厚生病院5;久留米大学6;九州がんセンター7;和歌山県立医科大学8;名古屋医療センター9;神戸中央市民病院10;飯塚病院11;株式会社テンクー12;武田薬品工業株式会社13;静岡がんセンター14;MD Anderson Cancer Center15;山口大学16
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション2
分子標的治療
座長:前門戸 任1, 堀尾 芳嗣2(岩手医科大学内科学講座呼吸器内科1, 愛知県がんセンター呼吸器内科2
*Koichi Goto1・Catherine A. Shu2・Yuichiro Ohe3・Benjamin Besse4・Se-Hoon Lee5・Yongsheng Wang6・Frank Griesinger7・James Chih-Hsin Yang8・Enriqueta Felip9・Rachel E. Sanborn10・Reyes Bernabe Caro11・Joshua C. Curtin12・Jun Chen12・Janine Mahoney12・Leonardo Trani12・Joshua M. Bauml12・Roland E. Knoblauch12・Meena Thayu12・Byoung Chul Cho13
National Cancer Center Hospital East, Kashiwa, Japan1;Columbia University Medical Center, New York, NY, USA2;National Cancer Center Hospital, Tokyo, Japan3;Paris-Sacaly University, Institut Gustave Roussy, Villejuif, France4;Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea5;West China Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, China6;Pius-Hospital, University of Oldenburg, Oldenburg, Germany7;National Taiwan University Cancer Center, Taiwan8;Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology, Barcelona, Spain9;Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA10;Hospital Universitario Virgen Del Rocio, Seville, Spain11;Janssen Research and Development, Spring House, PA, USA12;Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea13
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション2
分子標的治療
座長:前門戸 任1, 堀尾 芳嗣2(岩手医科大学内科学講座呼吸器内科1, 愛知県がんセンター呼吸器内科2
*Ryo Toyozawa1・Tatsuya Yoshida2・Toru Kumagai3・Makoto Nishio4・Takashi Seto5・Koichi Goto6・Kazuhiko Nakagawa7・Yuichiro Ohe2・Kentarou Kudou8・Takayuki Asato8・Pingkuan Zhang9・Nobuyuki Yamamoto10
National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan1;National Cancer Center Hospital, Tokyo, Japan2;Osaka International Cancer Institute, Osaka, Japan3;The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan4;National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan5;National Cancer Center Hospital East, Kashiwa, Japan6;Kindai University Faculty of Medicine, Osaka-Sayama, Japan7;Takeda Pharmaceutical Company Limited, Osaka, Japan8;Takeda Development Center Americas, Inc., Lexington, MA, USA9;Wakayama Medical University, Wakayama, Japan10
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション2
分子標的治療
座長:前門戸 任1, 堀尾 芳嗣2(岩手医科大学内科学講座呼吸器内科1, 愛知県がんセンター呼吸器内科2
*Hiroshi Sakai1・Masahiro Morise2・Terufumi Kato3・Shingo Matsumoto4・Takako Inoue5・Tomohiro Sakamoto6・Takaaki Tokito7・Shinji Atagi8・Toshiyuki Kozuki9・Hiroaki Takeoka10・Kenichi Chikamori11・Naofumi Shinagawa12・Hiroshi Tanaka13・S Peter Eggleton14・Rolf Bruns15・Gordon Otto14・Paul K. Paik16,17
Department of Thoracic Oncology, Ageo Central General Hospital, Ageo, Saitama, Japan1;Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan2;Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan3;Department of Thoracic Oncology, National Cancer Center Hospital East, Kashiwa City, Japan4;Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan5;Department of Respiratory Medicine, Tottori University Hospital, Yonago City, Japan6;Department of Internal Medicine, Kurume University School of Medicine, Kurume City, Japan7;Health Management Center, JCHO Yamatokoriyama Hospital, Yamatokoriyama City, Japan8;Department of Respiratory Medicine, NHO Shikoku Cancer Center, Matsuyama City, Japan9;Department of Respiratory Medicine, NHO Kyushu Medical Center, Fukuoka City, Japan10;Department of Oncology, NHO Yamaguchi - Ube Medical Center, Ube City, Japan11;Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan12;Department of Internal Medicine, Niigata Cancer Center Hospital, Niigata City, Japan13;Global Clinical Development, Merck Healthcare KGaA, Darmstadt, Germany14;Department of Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany15;Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA16;Department of Medicine, Weill Cornell Medical College, New York, NY, USA17
第63回日本肺癌学会学術集会 2022年12月開催

グローバルセッション2
分子標的治療
座長:前門戸 任1, 堀尾 芳嗣2(岩手医科大学内科学講座呼吸器内科1, 愛知県がんセンター呼吸器内科2
*Kazuto Nishio1・Kazuko Sakai1・Makoto Nishio2・Takashi Seto3・Carla Visseren-Grul4・Michelle Carlsen5・Sotaro Enatsu6・Tomoko Matsui6・Kazuhiko Nakagawa7
Department of Genome Biology, Kindai University Faculty of Medicine, Osaka, Japan1;Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan2;National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan3;Eli Lilly Netherlands, Utrecht, The Netherlands4;Eli Lilly and Company, Indianapolis, Indiana, USA5;Eli Lilly Japan K.K., Kobe, Japan6;Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan7
第63回日本肺癌学会学術集会 2022年12月開催

ページの先頭へ